Your browser doesn't support javascript.
loading
Effect of IBD medications on COVID-19 outcomes: results from an international registry.
Ungaro, Ryan C; Brenner, Erica J; Gearry, Richard B; Kaplan, Gilaad G; Kissous-Hunt, Michele; Lewis, James D; Ng, Siew C; Rahier, Jean-Francois; Reinisch, Walter; Steinwurz, Flávio; Underwood, Fox E; Zhang, Xian; Colombel, Jean-Frederic; Kappelman, Michael D.
Afiliação
  • Ungaro RC; The Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA ryan.ungaro@mssm.edu.
  • Brenner EJ; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Gearry RB; Department of Medicine, University of Otago, Christchurch, New Zealand.
  • Kaplan GG; Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
  • Kissous-Hunt M; The Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Lewis JD; Fifth Ave GI, New York, New York, USA.
  • Ng SC; Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Rahier JF; Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Science, Chinese University of Hong Kong, Shatin, NT, Hong Kong.
  • Reinisch W; Department of Gastroenterology, Université Catholique de Louvain, Yvoir, Belgium.
  • Steinwurz F; Department of Medicine IV, Medical University Vienna, Vienna, Austria.
  • Underwood FE; Department of Gastroenterology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
  • Zhang X; Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
  • Colombel JF; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Kappelman MD; The Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Gut ; 70(4): 725-732, 2021 04.
Article em En | MEDLINE | ID: mdl-33082265
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azatioprina / Doenças Inflamatórias Intestinais / Inibidores do Fator de Necrose Tumoral / SARS-CoV-2 / COVID-19 / Mercaptopurina Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azatioprina / Doenças Inflamatórias Intestinais / Inibidores do Fator de Necrose Tumoral / SARS-CoV-2 / COVID-19 / Mercaptopurina Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article